[{"from": "human", "value": "Describe this molecule. [C][C][N][C][=Branch1][C][=O][C][C][C][/C][=C][\\C][C@H1][C@H1][Branch2][Ring1][#Branch2][C][C@H1][Branch2][Ring1][Ring2][C@@H1][Ring1][Branch1][/C][=C][/C@H1][Branch1][O][C][C][C][=C][C][=C][C][=C][Ring1][=Branch1][O][O][O]"}, {"from": "gpt", "value": "The molecule are synthetic structural analogs of prostaglandin. Bimatoprost, marketed by Allergan, is administered in both the ophthalmic solution and implant form. It has the ability to reduce ocular hypotension, proving effective in conditions such as ocular hypertension and glaucoma. Bimatoprost is also used to treat eyelash hypotrichosis, or sparse eyelash growth. It was initially approved by the FDA in 2001 for ocular hypertension and later approved for hypothrichosis in 2008, as eyelash growth became a desirable adverse effect for patients using this drug."}]